Automated Cell Counters Market Overview and Growth by 2028

The automated cell counters market is expected to grow from US$ 6,974.29 million in 2021 to US$ 10,365.95 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028.
The market growth is attributed to the high prevalence of infectious and chronic diseases.

The automated cell counters market comprises major competitive players who adopt various strategies, such as product launches, geographic expansion, and technological advancements. A few recent developments in the market are listed below:

In April 2021, Eppendorf announced the launching of a new product, "Centrifuge 5910 Ri", designed to increase laboratory efficiency. This new centrifuge is a successor to the popular Centrifuge 5910 R, and is a flagship of Eppendorf's multipurpose centrifuge portfolio that offers scientists advanced features to simplify and accelerate the centrifugation steps.
In August 2019, Agilent Technologies, Inc. announced the acquisition of Biotek Instruments, a pioneer in the design, manufacture, and distribution of innovative life science instrumentation. The acquisition results in the expansion of Agilent's presence and expertise in cell analysis and strengthens the company's position in the large and growing immuno-oncology and immunotherapy areas.

Read More: - https://www.theinsightpartners.com/reports/automated-cell-counters-market
Automated Cell Counters Market Overview and Growth by 2028 The automated cell counters market is expected to grow from US$ 6,974.29 million in 2021 to US$ 10,365.95 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028. The market growth is attributed to the high prevalence of infectious and chronic diseases. The automated cell counters market comprises major competitive players who adopt various strategies, such as product launches, geographic expansion, and technological advancements. A few recent developments in the market are listed below: In April 2021, Eppendorf announced the launching of a new product, "Centrifuge 5910 Ri", designed to increase laboratory efficiency. This new centrifuge is a successor to the popular Centrifuge 5910 R, and is a flagship of Eppendorf's multipurpose centrifuge portfolio that offers scientists advanced features to simplify and accelerate the centrifugation steps. In August 2019, Agilent Technologies, Inc. announced the acquisition of Biotek Instruments, a pioneer in the design, manufacture, and distribution of innovative life science instrumentation. The acquisition results in the expansion of Agilent's presence and expertise in cell analysis and strengthens the company's position in the large and growing immuno-oncology and immunotherapy areas. Read More: - https://www.theinsightpartners.com/reports/automated-cell-counters-market
WWW.THEINSIGHTPARTNERS.COM
Automated Cell Counters Market Regional Overview by 2028
Automated Cell Counters Market share is anticipated to reach US$ 10.37 Billion by 2028, growing with a lucrative CAGR value. Report on top players and trends
0 Comments 0 Shares 0 Reviews
Sponsored
Sponsored